BioPortUSA is excited to announce the addition of AstraCon, a German based regulatory consulting firm focused on IVD and medical device companies. “We asked AstraCon to join BioPort after working together with a mutual client that was German who needed help with Market Entry into the USA. We recognized their strategic value in being a beacon for us in the German market, said Mark Lesselroth, CEO of BioPortUSA. Conversely, Carmen Peeß, Managing Director of AstraCon recognized “that having a partnership with BioPortUSA would help their clients navigate the challenges with entering the US market.”
Both organizations are committed to not only helping one another out but identifying opportunities for joint collaboration and presentations about their respective markets and the corresponding healthcare system.